These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 9626486)

  • 1. Prostate cancer switch may yield map of cancer machinery, targets for drugs.
    Compr Ther; 1998 May; 24(5):276-8. PubMed ID: 9626486
    [No Abstract]   [Full Text] [Related]  

  • 2. Heterogeneity of molecular targets on clonal cancer lines derived from a novel hormone-refractory prostate cancer tumor system.
    Freedland SJ; Pantuck AJ; Paik SH; Zisman A; Graeber TG; Eisenberg D; McBride WH; Nguyen D; Tso CL; Belldegrun AS
    Prostate; 2003 Jun; 55(4):299-307. PubMed ID: 12712409
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fibroblast growth factor 17 is over-expressed in human prostate cancer.
    Heer R; Douglas D; Mathers ME; Robson CN; Leung HY
    J Pathol; 2004 Dec; 204(5):578-86. PubMed ID: 15538740
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of gene expression identifies candidate markers and pharmacological targets in prostate cancer.
    Welsh JB; Sapinoso LM; Su AI; Kern SG; Wang-Rodriguez J; Moskaluk CA; Frierson HF; Hampton GM
    Cancer Res; 2001 Aug; 61(16):5974-8. PubMed ID: 11507037
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of fibroblast growth factors and their receptors in prostate cancer.
    Kwabi-Addo B; Ozen M; Ittmann M
    Endocr Relat Cancer; 2004 Dec; 11(4):709-24. PubMed ID: 15613447
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stromal anti-apoptotic androgen receptor target gene c-FLIP in prostate cancer.
    Ye H; Li Y; Melamed J; Pearce P; Wei J; Chiriboga L; Wang Z; Osman I; Lee P
    J Urol; 2009 Feb; 181(2):872-7. PubMed ID: 19095249
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The insulin-like growth factor axis and prostate cancer: lessons from the transgenic adenocarcinoma of mouse prostate (TRAMP) model.
    Kaplan PJ; Mohan S; Cohen P; Foster BA; Greenberg NM
    Cancer Res; 1999 May; 59(9):2203-9. PubMed ID: 10232609
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adenovirus-mediated expression of a soluble fibroblast growth factor receptor inhibits in vitro growth of prostate DU145 cells.
    Gowardhan B; West AF; Robson CN; Leung HY
    Prostate; 2004 Sep; 61(1):50-9. PubMed ID: 15287093
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overexpression of the cyclin-dependent kinase inhibitor p16 is associated with tumor recurrence in human prostate cancer.
    Lee CT; Capodieci P; Osman I; Fazzari M; Ferrara J; Scher HI; Cordon-Cardo C
    Clin Cancer Res; 1999 May; 5(5):977-83. PubMed ID: 10353729
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selenite treatment inhibits LAPC-4 tumor growth and prostate-specific antigen secretion in a xenograft model of human prostate cancer.
    Bhattacharyya RS; Husbeck B; Feldman D; Knox SJ
    Int J Radiat Oncol Biol Phys; 2008 Nov; 72(3):935-40. PubMed ID: 18760546
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Androgen receptor outwits prostate cancer drugs.
    Isaacs JT; Isaacs WB
    Nat Med; 2004 Jan; 10(1):26-7. PubMed ID: 14702629
    [No Abstract]   [Full Text] [Related]  

  • 12. Editorial comment on: ADAM9 expression is a significant and independent prognostic marker of PSA relapse in prostate cancer.
    Cooper C
    Eur Urol; 2008 Nov; 54(5):1107-8. PubMed ID: 18061340
    [No Abstract]   [Full Text] [Related]  

  • 13. Editorial comment on: ADAM9 expression is a significant and independent prognostic marker of PSA relapse in prostate cancer.
    Valentini A; Bernardini S
    Eur Urol; 2008 Nov; 54(5):1106-7. PubMed ID: 18061338
    [No Abstract]   [Full Text] [Related]  

  • 14. The Src-suppressed C kinase substrate, SSeCKS, is a potential metastasis inhibitor in prostate cancer.
    Xia W; Unger P; Miller L; Nelson J; Gelman IH
    Cancer Res; 2001 Jul; 61(14):5644-51. PubMed ID: 11454719
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vascular endothelial growth factor and basic fibroblast growth factor urine levels as predictors of outcome in hormone-refractory prostate cancer patients: a cancer and leukemia group B study.
    Bok RA; Halabi S; Fei DT; Rodriquez CR; Hayes DF; Vogelzang NJ; Kantoff P; Shuman MA; Small EJ
    Cancer Res; 2001 Mar; 61(6):2533-6. PubMed ID: 11289126
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression profiling of microdissected matched prostate cancer samples reveals CD166/MEMD and CD24 as new prognostic markers for patient survival.
    Kristiansen G; Pilarsky C; Wissmann C; Kaiser S; Bruemmendorf T; Roepcke S; Dahl E; Hinzmann B; Specht T; Pervan J; Stephan C; Loening S; Dietel M; Rosenthal A
    J Pathol; 2005 Feb; 205(3):359-76. PubMed ID: 15532095
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stage-specific characterization of the vascular endothelial growth factor axis in prostate cancer: expression of lymphangiogenic markers is associated with advanced-stage disease.
    Kaushal V; Mukunyadzi P; Dennis RA; Siegel ER; Johnson DE; Kohli M
    Clin Cancer Res; 2005 Jan; 11(2 Pt 1):584-93. PubMed ID: 15701844
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of RAC 3, a steroid hormone receptor co-activator in prostate cancer.
    Gnanapragasam VJ; Leung HY; Pulimood AS; Neal DE; Robson CN
    Br J Cancer; 2001 Dec; 85(12):1928-36. PubMed ID: 11747336
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differently regulated androgen receptor transcriptional complex in prostate cancer compared with normal prostate.
    Kinoshita M; Nakagawa T; Shimizu A; Katsuoka Y
    Int J Urol; 2005 Apr; 12(4):390-7. PubMed ID: 15948728
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gene amplifications associated with the development of hormone-resistant prostate cancer.
    Edwards J; Krishna NS; Witton CJ; Bartlett JM
    Clin Cancer Res; 2003 Nov; 9(14):5271-81. PubMed ID: 14614009
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.